| 名称 | Diosmetin |
| 描述 | Diosmetin (Luteolin 4-methyl ether) has been found to act as a weak TrkB receptor agonist. |
| 细胞实验 | Diosmetin is dissolved in DMSO which is maintained at a constant concentration in control samples (2%). HepG2 cells are maintained in a humidified atmosphere of 5% CO2 at 37°C, and cultured in RPMI-1640 medium supplemented with 10% (v/v) fetal bovine serum, 100 U/mL penicillin and 100 U/mL streptomycin. HepG2 cell density is adjusted to 2×104 cells/100 μL, and the cells are seeded into 96-well plates and placed in an incubator overnight (37°C in 5% CO2) to allow for attachment and recovery. MTT analyses are performed. Briefly, cells are pretreated with 5, 10, 15 and 20 μg/mL diosmetin for 24 h. A total of 20 μL MTT solution (5 mg/mL in PBS) solution is transferred to each well to yield a final 120 μL/well and to separate wells a total of 10 μL CCK8 (5 mg/mL in PBS) is transferred. The plates are incubated for 4 h at 37°C in 5% CO2 and the absorbance is recorded at wavelengths of 595 nm and 450 nm, respectively. The half maximal inhibitory concentration (IC50) of diosmetin is calculated[1]. |
| 激酶实验 | Topoisomerase I Assay: One unit (the minimum amount for full relaxation of 0.5 μg SV40 DNA under the conditions of this study) of topoisomerase I, 0.5 μL of the test compounds, and 0.5μg SV40 DNA are added sequentially to the reaction buffer, which is composed of 25 mM Tris-HCl (pH 7.5), 50 mM KC1, 5 mM MgCl2, 0.25 mM EDTA disodium salt, 0.25 mM dithiothreitol, 15μg /mL bovine serum albumin, and 5% glycerol. Then, the reaction mixture (50 μL) is incubated for 10 min at 37 °C, and the reaction is terminated by treatment with 7.5 μL of a solution consisting of 1% sodium dodecyl sulfate, 20 mM EDTA disodium salt, and 0.5 mg/mL proteinase K for an additional 30 min at 37°C. The samples are mixed with 5 μL of the loading buffer containing 10 mM Na2HPO4, 31.3% sucrose, and 0.3% bromophenol blue. Relaxed (form Ir) DNA is separated from supercoiled (form I) and nicked (form II) DNA by electrophoresis on 0.8% agarose gel at 50 mA and 20 V for 17 h in the presence of 2 μg/mL chloroquine, 10 mM EDTA, 30 mM NaH2PO4, and 36 Mm Tris-HCl (pH 7.8). After electrophoresis, the gel is stained with 0.05% ethidium bromide and photographed with UV light (302 nm). The amount of DNA is quantified using a densitometer. |
| 体内活性 | 在首次注射蓝铜胆素后的6小时、9小时及12小时，通过生化和形态学方法评估急性胰腺炎的严重程度。预处理Diosmetin显著降低了血清淀粉酶和脂肪酶水平，抑制肿瘤坏死因子(TNF)-α、白细胞介素(IL)-1β和IL-6的分泌，抑制髓过氧化物酶(MPO)活性和胰蛋白酶原激活肽(TAP)水平，诱导一氧化氮合酶(iNOS)的表达，诱导蓝铜胆素诱导的AP中核因子(NF)-κB激活。这项研究显示，Diosmetin的给药对小鼠蓝铜胆素诱导的AP进程有益效果。因此，Diosmetin可能成为未来临床试验中治疗AP的新疗法。 |
| 存储条件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度 | H2O : < 1 mg/mL (insoluble or slightly soluble)
DMSO : 39 mg/mL (129.89 mM), Sonication is recommended.
Ethanol : < 1 mg/mL (insoluble or slightly soluble)
10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (6.66 mM), Sonication is recommended.
|
| 关键字 | Trkreceptor | TrkB | Trk receptor | Inhibitor | inhibit | Diosmetin | Cytochrome P450 | CYPs | CYP1A1 |
| 相关产品 | Naringin | Musk ketone | Ipriflavone | Benzyl alcohol | Memantine hydrochloride | Clarithromycin | Chlorzoxazone | Sudan IV | Naringin dihydrochalcone | Dibenzothiophene | Oxadiazon | Tebuconazole |
| 相关库 | 经典已知活性库 | 清热解毒中药单体库 | 古代经典名方目录分子库 | 黄酮类天然产物库 | 苗药化合物库 | 药食同源库 | 抗癌天然产物库 | 抗衰老化合物库 | 中药单体化合物库 | 烟草单体化合物库 | 膜蛋白靶向化合物库 | 天然多酚类化合物库 |